Fresh analysis indicates that people who discontinue new GLP-1 drugs like Mounjaro or Wegovy may regain reduced body mass much more quickly than those who end conventional lifestyle regimens.
Published data in a major health publication demonstrates that while overweight people can lose a large proportion of their body weight while using the jabs, the weight is regained at an estimated rate of 0.8 kg per month upon discontinuation.
"Individuals buying these medications need to be informed of the danger of quick weight regain when the medication concludes," stated researcher Dr. Susan Jebb.
Such speed of recovery suggests a reversion to pre-treatment mass in about a year and a half.
Weighing Therapies
The research, which reviewed 37 of trials involving thousands of patients, contrasted the results of these new drugs with other pills.
The team point out that people who lose weight through dieting generally see a slower creep back—perhaps 0.1 kg a month—post-intervention.
Understanding the Fast Regain
Experts suggest the mechanism of the jabs is key to understanding the amplified rebound.
These medications copy a natural hormone called glucagon-like peptide-1, which controls hunger.
"Sustained high doses of the hormone levels several times higher than the body's typical production could lead to the system to produce less of its own natural hormone, and could lessen responsiveness to its effects," explained Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this hormone supplement leads to appetite is uncontrolled, making binge eating a significant risk."
An Ongoing Disease?
Health authorities recommend the jabs for people with obesity-related health risks, accompanied by recommended lifestyle changes.
A number of clinicians argue that, due to the significant potential of relapse, the treatment is often ongoing.
This perspective is reinforced by drug manufacturers, who say that the results "underscore the long-term character of obesity," akin to managing conditions like high blood pressure.
Patient Testimonies
Individuals who have stopped the medication report a sudden return of appetite.
"It was like something flipping and you're instantly ravenous," described one woman.
This difficulty is exacerbated if patients have not established permanent dietary or behavioural changes during treatment.
Significant Interest
Survey data show that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with interest remaining high.
- Use is higher among females compared to men.
- The middle-aged age group shows the highest usage rates.
- A large proportion obtain the medications through private healthcare rather than the NHS.
Ultimately, experts stress that while GLP-1 drugs are potent agents for weight loss, they are not a magic cure and long-term success likely depends on combined behavioural support.
